| Literature DB >> 35819454 |
Stig Brorson1, Joanne Elliott2, Theis Thillemann3, Patricia Aluko4, Helen Handoll5.
Abstract
Entities:
Mesh:
Year: 2022 PMID: 35819454 PMCID: PMC9275419 DOI: 10.2340/17453674.2022.3495
Source DB: PubMed Journal: Acta Orthop ISSN: 1745-3674 Impact factor: 3.925
Grades of evidence
| High certainty: | we are very confident that the true effect lies close to that of the estimate of the effect |
| Moderate certainty: | we are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different |
| Low certainty: | our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of the effect |
| Very low certainty: | we have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of the effect |
Modified summary of findings for comparison of surgical versus non-surgical treatment
| Patients: older patients with displaced (Neer) proximal humeral fractures treated at hospital (10 trials, 717 participants) | ||||||
|---|---|---|---|---|---|---|
| Outcomes | Illustrative comparative risks | Relative effect (95% CI) | No. of participants (studies) | Certainty of the evidence (GRADE) | Comments | |
| Assumed risk Non-surgical treatment | Corresponding risk Surgical treatment | |||||
| Functional scores | The overall mean difference in function was 0.10 SD higher (0.07 lower to 0.27 higher) | SMD 0.10 | 552 participants (7 studies) | ⊕⊕⊕⊕ High | All estimates of between-group differences were smaller than the predefined MCID for individual scores | |
| Quality of life: EQ-5D (1: best quality of life) Follow-up: 1 year | Mean score ranged from 0.65 to 0.90 | The mean EQ-5D score in the surgery groups was 0.01 higher (0.02 lower to 0.04 higher) | MD 0.01 (–0.02 to 0.04) | 502 participants (6 studies) | ⊕⊕⊕⊕ High | The MCID of 0.12 was outside the 95% CI at this time period. |
| Additional surgery (re-operation or secondary surgery) Follow-up: up to 2 years | 35 per 1,000 | 73 per 1,000 (43–129) | RR 2.06 (1.21–3.51) | 667 participants (9 studies) | ⊕⊕⊕⊕ Low | Additional surgery was reported for 54 participants in total. |
CI: confidence interval; EQ-5D: European Quality of Life-5 Dimensions; MCID: minimal clinically important difference; MD: mean difference; RR: risk ratio; SMD: standardised mean difference
American Shoulder and Elbow Surgeons score (ASES; 1 trial), Disability of the Arm, Shoulder and Hand questionnaire (DASH; 4 trials), Oxford Shoulder Score (OSS; 1 trial); Simple Shoulder Test (SST; 1 trial)
SMD 0.2: small difference, 0.5: moderate difference, 0.8 large difference
Figure 1Surgical versus non-surgical treatment: functional scores at 12 months
Figure 2Surgical versus non-surgical treatment: additional surgery (re-operation or secondary surgery)